Peel Therapeutics

Biotechnology ResearchUtah, United States11-50 Employees

Peel Therapeutics is a biotechnology research company based in Salt Lake City, Utah. It focuses on translating evolutionary outliers into medicines for cancer and inflammatory diseases, addressing solubility, scalability, and bioavailability in its clinical-stage pipeline. In April 2023, Peel Therapeutics announced the development of first-in-class neutrophil-targeting peptides derived from natural NET inhibitors found in newborns to block inflammation linked to immunothrombosis and fibrosis. The company appears to operate with a relatively small to mid-sized team within the biotechnology sector. Peel Therapeutics is positioned at the intersection of biology and drug development, pursuing therapies through biotech research methods.

Sign up for free to view info

Email Format Employee directory